Article
Impact of Lenvatinib on OATP1B Activity in Patients with Hepatocellular Carcinoma
2026-05-12
Abstract excerpt
<b>Aims: </b>Lenvatinib (LEN) inhibits organic anion transporting polypeptide 1B1 (OATP1B1) <i>in vitro</i>, raising concerns about potential risk for transporter-mediated drug–drug interactions (DDIs). This study evaluated the <i>in vivo</i> impact of LEN on OATP1B activity in patients with hepatocellular carcinoma (HCC), using coproporphyrin-I (CP-I) as an endogenous biomarker. <b>Methods:</b> In this prospectiv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 83866dc7-0c77-53e0-8c04-3bdecbc295de
- DOI
- 10.22541/authorea.15003181/v1
